Ultragenyx wins accelerated approval of gene therapy for glycogen storage disease

· seekingalpha.com

FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy for GSDIa, cutting cornstarch supplement needs. Read more here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

If you have an ad-blocker enabled you may be blocked from ...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI